The Principal Genetic Determinants for Nasopharyngeal Carcinoma in China Involve the Class I Antigen Recognition Groove

English version České info

Nasopharyngeal carcinoma (NPC) is an epithelial malignancy facilitated by Epstein-Barr Virus infection. Here we resolve the major genetic influences for NPC incidence using a genome-wide association study (GWAS), independent cohort replication, and high-resolution molecular HLA class I gene typing including 4,055 study participants from the Guangxi Zhuang Autonomous Region and Guangdong province of southern China. We detect and replicate strong association signals involving SNPs, HLA alleles, and amino acid (aa) variants across the major histocompatibility complex-HLA-A, HLA –B, and HLA -C class I genes (P_{HLA-A-aa-site-62} = 7.4×10⁻²⁹; P _{HLA-B-aa-site-116} = 6.5×10⁻¹⁹; P _{HLA-C-aa-site-156} = 6.8×10⁻⁸ respectively). Over 250 NPC-HLA associated variants within HLA were analyzed in concert to resolve separate and largely independent HLA-A, -B, and -C gene influences. Multivariate logistical regression analysis collapsed significant associations in adjacent genes spanning 500 kb (OR2H1, GABBR1, HLA-F, and HCG9) as proxies for peptide binding motifs carried by HLA- A*11:01. A similar analysis resolved an independent association signal driven by HLA-B*13:01, B*38:02, and B*55:02 alleles together. NPC resistance alleles carrying the strongly associated amino acid variants implicate specific class I peptide recognition motifs in HLA-A and -B peptide binding groove as conferring strong genetic influence on the development of NPC in China.

Vyšlo v časopise: The Principal Genetic Determinants for Nasopharyngeal Carcinoma in China Involve the Class I Antigen Recognition Groove. PLoS Genet 8(11): e32767. doi:10.1371/journal.pgen.1003103
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1003103

Souhrn

Zdroje

1. JemalA, BrayF, CenterMM, FerlayJ, WardE, et al. (2011) Global cancer statistics. CA Cancer J Clin 61: 69–90.

2. HenleG, HenleW (1976) Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma. Int J Cancer 17: 1–7.

3. ZengY, ZhangLG, LiHY, JanMG, ZhangQ, et al. (1982) Serological mass survey for early detection of nasopharyngeal carcinoma in Wuzhou City, China. Int J Cancer 29: 139–141.

4. ZengY, ZhangLG, WuYC, HuangYS, HuangNQ, et al. (1985) Prospective studies on nasopharyngeal carcinoma in Epstein-Barr virus IgA/VCA antibody-positive persons in Wuzhou City, China. Int J Cancer 36: 545–547.

5. NgWT, YauTK, YungRW, SzeWM, TsangAH, et al. (2005) Screening for family members of patients with nasopharyngeal carcinoma. Int J Cancer 113: 998–1001.

6. CoffinCM, RichSS, DehnerLP (1991) Familial aggregation of nasopharyngeal carcinoma and other malignancies. A clinicopathologic description. Cancer 68: 1323–1328.

7. SimonsMJ, WeeGB, ChanSH, ShanmugaratnamK, DayNE, et al. (1975) Immunogenetic aspects of nasopharyngeal carcinoma (NPC) III. HL-a type as a genetic marker of NPC predisposition to test the hypothesis that Epstein-Barr virus is an etiological factor in NPC. IARC Sci Publ 249–258.

8. ChanSH, DayNE, KunaratnamN, ChiaKB, SimonsMJ (1983) HLA and nasopharyngeal carcinoma in Chinese–a further study. Int J Cancer 32: 171–176.

9. LuSJ, DayNE, DegosL, LepageV, WangPC, et al. (1990) Linkage of a nasopharyngeal carcinoma susceptibility locus to the HLA region. Nature 346: 470–471.

10. HildesheimA, AppleRJ, ChenCJ, WangSS, ChengYJ, et al. (2002) Association of HLA class I and II alleles and extended haplotypes with nasopharyngeal carcinoma in Taiwan. J Natl Cancer Inst 94: 1780–1789.

11. HuSP, DayNE, LiDR, LubenRN, CaiKL, et al. (2005) Further evidence for an HLA-related recessive mutation in nasopharyngeal carcinoma among the Chinese. Br J Cancer 92: 967–970.

12. YuKJ, GaoX, ChenCJ, YangXR, DiehlSR, et al. (2009) Association of human leukocyte antigens with nasopharyngeal carcinoma in high-risk multiplex families in Taiwan. Hum Immunol 70: 910–914.

13. TangM, ZengY, PoissonA, MartiD, GuanL, et al. (2010) Haplotype-dependent HLA susceptibility to nasopharyngeal carcinoma in a Southern Chinese population. Genes Immun 11: 334–342.

14. ReillyMP, LiM, HeJ, FergusonJF, StylianouIM, et al. (2011) Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies. Lancet 377: 383–392.

15. SeshadriS, FitzpatrickAL, IkramMA, DeStefanoAL, GudnasonV, et al. (2010) Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA 303: 1832–1840.

16. YangJJ, PlengeRM (2011) Genomic technology applied to pharmacological traits. JAMA 306: 652–653.

17. NgCC, YewPY, PuahSM, KrishnanG, YapLF, et al. (2009) A genome-wide association study identifies ITGA9 conferring risk of nasopharyngeal carcinoma. J Hum Genet 54: 392–397.

18. TseKP, SuWH, ChangKP, TsangNM, YuCJ, et al. (2009) Genome-wide association study reveals multiple nasopharyngeal carcinoma-associated loci within the HLA region at chromosome 6p21.3. Am J Hum Genet 85: 194–203.

19. BeiJX, LiY, JiaWH, FengBJ, ZhouG, et al. (2010) A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci. Nat Genet 42: 599–603.

20. GuoXC, ScottK, LiuY, DeanM, DavidV, et al. (2006) Genetic factors leading to chronic Epstein-Barr virus infection and nasopharyngeal carcinoma in South East China: study design, methods and feasibility. Hum Genomics 2: 365–375.

21. GuoX, JohnsonRC, DengH, LiaoJ, GuanL, et al. (2009) Evaluation of non-viral risk factors for nasopharyngeal carcinoma in a high-risk population of Southern China. International Journal of Cancer 124: 2942–2947.

22. BjorkmanPJ, SaperMA, SamraouiB, BennettWS, StromingerJL, et al. (1987) The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature 329: 512–518.

23. LundO, NielsenM, KesmirC, PetersenAG, LundegaardC, et al. (2004) Definition of supertypes for HLA molecules using clustering of specificity matrices. Immunogenetics 55: 797–810.

24. KarpDR, MarthandanN, MarshSG, AhnC, ArnettFC, et al. (2010) Novel sequence feature variant type analysis of the HLA genetic association in systemic sclerosis. Hum Mol Genet 19: 707–719.

25. PurcellS, NealeB, Todd-BrownK, ThomasL, FerreiraMA, et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81: 559–575.

26. GaoX, NelsonGW, KarackiP, MartinMP, PhairJ, et al. (2001) Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. N Engl J Med 344: 1668–1675.

27. ThammavongsaV, SchaeferM, FilzenT, CollinsKL, CarringtonM, et al. (2009) Assembly and intracellular trafficking of HLA-B*3501 and HLA-B*3503. Immunogenetics 61: 703–716.

28. SteinleA, FalkK, RotzschkeO, GnauV, StevanovicS, et al. (1996) Motif of HLA-B*3503 peptide ligands. Immunogenetics 43: 105–107.

29. BashirovaAA, ThomasR, CarringtonM (2011) HLA/KIR restraint of HIV: surviving the fittest. Annu Rev Immunol 29: 295–317.

30. HuangJ, GoedertJJ, SundbergEJ, CungTD, BurkePS, et al. (2009) HLA-B*35-Px-mediated acceleration of HIV-1 infection by increased inhibitory immunoregulatory impulses. J Exp Med 206: 2959–2966.

31. KulkarniS, SavanR, QiY, GaoX, YukiY, et al. (2011) Differential microRNA regulation of HLA-C expression and its association with HIV control. Nature 472: 495–498.

32. Hurley C (2005) IHWG Technology Core Joint Report; Hansen JA, Dupont B, editors: Immunobiology of the Human MHC: Proceedings of the 13th International Hisotcompatibility Workshop and Conference, Fred Hutchinson Cancer Research.

33. PriceAL, PattersonNJ, PlengeRM, WeinblattME, ShadickNA, et al. (2006) Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 38: 904–909.